• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含复杂非离子表面活性剂的氯雷他定 III 型脂质体制剂的计算和实验模型。

Computational and Experimental Models of Type III Lipid-Based Formulations of Loratadine Containing Complex Nonionic Surfactants.

机构信息

Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

Mol Pharm. 2021 Dec 6;18(12):4354-4370. doi: 10.1021/acs.molpharmaceut.1c00547. Epub 2021 Nov 22.

DOI:10.1021/acs.molpharmaceut.1c00547
PMID:34807627
Abstract

Type III lipid-based formulations (LBFs) combine poorly water-soluble drugs with oils, surfactants, and cosolvents to deliver the drugs into the systemic circulation. However, the solubility of the drug can be influenced by the colloidal phases formed in the gastrointestinal tract as the formulation is dispersed and makes contact with bile and other materials present within the GI tract. Thus, an understanding of the phase behavior of LBFs in the gut is critical for designing efficient LBFs. Molecular dynamics (MD) simulation is a powerful tool for the study of colloidal systems. In this study, we modeled the internal structures of five type III LBFs of loratadine containing poly(ethylene oxide) nonionic surfactants polysorbate 80 and polyoxyl hydrogenated castor oil (Kolliphor RH40) using long-timescale MD simulations (0.4-1.7 μs). We also conducted experimental investigations (dilution of formulations with water) including commercial Claritin liquid softgel capsules. The simulations show that LBFs form continuous phase, water-swollen reverse micelles, and bicontinuous and phase-separated systems at different dilutions, which correlate with the experimental observations. This study supports the use of MD simulation as a predictive tool to determine the fate of LBFs composed of medium-chain lipids, polyethylene oxide surfactants, and polymers.

摘要

III 型脂质基制剂 (LBF) 将难溶于水的药物与油、表面活性剂和共溶剂结合,将药物递送到体循环中。然而,药物的溶解度可能会受到胃肠道中形成的胶体相的影响,因为制剂在分散并与胆汁和胃肠道中存在的其他物质接触时会形成胶体相。因此,了解 LBF 在肠道中的相行为对于设计高效的 LBF 至关重要。分子动力学 (MD) 模拟是研究胶体系统的有力工具。在这项研究中,我们使用长时间尺度的 MD 模拟 (0.4-1.7 μs) 对含有聚氧乙烯非离子表面活性剂聚山梨酯 80 和聚氧乙烯氢化蓖麻油 (Kolliphor RH40) 的五种 loratadine III 型 LBF 的内部结构进行了建模。我们还进行了实验研究(用水稀释制剂),包括商业的 Claritin 液体软胶囊。模拟表明,LBFs 在不同稀释度下形成连续相、水增溶的反向胶束、双连续相和相分离体系,这与实验观察结果相关。这项研究支持使用 MD 模拟作为预测工具来确定由中链脂质、聚氧乙烯表面活性剂和聚合物组成的 LBF 的命运。

相似文献

1
Computational and Experimental Models of Type III Lipid-Based Formulations of Loratadine Containing Complex Nonionic Surfactants.含复杂非离子表面活性剂的氯雷他定 III 型脂质体制剂的计算和实验模型。
Mol Pharm. 2021 Dec 6;18(12):4354-4370. doi: 10.1021/acs.molpharmaceut.1c00547. Epub 2021 Nov 22.
2
In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.采用分散和消化试验对无药物和非诺贝特载脂体制剂进行体外评估,可深入了解制剂在肠道中的可能命运。
Eur J Pharm Sci. 2013 Jul 16;49(4):748-60. doi: 10.1016/j.ejps.2013.04.036. Epub 2013 May 16.
3
Molecular Dynamics Simulation Studies of Bile, Bile Salts, Lipid-Based Drug Formulations, and mRNA-Lipid Nanoparticles: A Review.胆汁、胆盐、脂质药物制剂和mRNA脂质纳米颗粒的分子动力学模拟研究:综述
Mol Pharm. 2023 Jun 5;20(6):2781-2800. doi: 10.1021/acs.molpharmaceut.3c00049. Epub 2023 May 17.
4
Molecular Dynamics Simulations and Experimental Results Provide Insight into Clinical Performance Differences between Sandimmune® and Neoral® Lipid-Based Formulations.分子动力学模拟和实验结果深入了解了 Sandimmune®和 Neoral®两种基于脂质的制剂在临床性能上的差异。
Pharm Res. 2021 Sep;38(9):1531-1547. doi: 10.1007/s11095-021-03099-5. Epub 2021 Sep 24.
5
Intrinsic lipolysis rate for systematic design of lipid-based formulations.基于脂质的制剂系统设计的内在脂解率。
Drug Deliv Transl Res. 2023 May;13(5):1288-1304. doi: 10.1007/s13346-022-01246-y. Epub 2022 Oct 8.
6
Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.辛尼嗪从 II 型脂质体制剂中的吸收:脂质链长、过饱和度、消化和沉淀抑制的影响。
Eur J Pharm Sci. 2024 Jun 1;197:106765. doi: 10.1016/j.ejps.2024.106765. Epub 2024 Apr 10.
7
Molecular Structuring and Phase Transition of Lipid-Based Formulations upon Water Dispersion: A Coarse-Grained Molecular Dynamics Simulation Approach.基于水相分散的脂质体制剂的分子结构和相转变:一种粗粒度分子动力学模拟方法。
Mol Pharm. 2017 Dec 4;14(12):4145-4153. doi: 10.1021/acs.molpharmaceut.7b00397. Epub 2017 Aug 29.
8
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.“隐形”脂质制剂:聚乙二醇介导的消化抑制作用提高了模型难溶性药物的口服生物利用度。
J Control Release. 2014 Oct 28;192:219-27. doi: 10.1016/j.jconrel.2014.07.037. Epub 2014 Jul 22.
9
A Nonionic Polyethylene Oxide (PEO) Surfactant Model: Experimental and Molecular Dynamics Studies of Kolliphor EL.一种非离子型聚环氧乙烷(PEO)表面活性剂模型:Kolliphor EL 的实验和分子动力学研究。
J Pharm Sci. 2019 Jan;108(1):193-204. doi: 10.1016/j.xphs.2018.11.028. Epub 2018 Nov 28.
10
Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.为了建立标准化的基于脂质的制剂的体外测试方法。2. 胆汁盐浓度和药物载药量对 I 型、II 型、IIIA 型、IIIB 型和 IV 型制剂在体外消化过程中的性能的影响。
Mol Pharm. 2012 Nov 5;9(11):3286-300. doi: 10.1021/mp300331z. Epub 2012 Oct 22.

引用本文的文献

1
Lipid-based oral formulation in capsules to improve the delivery of poorly water-soluble drugs.用于改善难溶性药物递送的胶囊型脂质口服制剂。
Front Drug Deliv. 2023 Aug 24;3:1232012. doi: 10.3389/fddev.2023.1232012. eCollection 2023.
2
Structural properties of conductive polymer blends interfaced with water: computational insights from PEDOT:PSS.与水接触的导电聚合物共混物的结构特性:来自聚(3,4-乙撑二氧噻吩):聚苯乙烯磺酸盐的计算见解
J Mater Chem C Mater. 2024 Oct 18;12(47):19245-19257. doi: 10.1039/d4tc03066d. eCollection 2024 Dec 5.